Cointime

BigHat Biosciences

company

About

BigHat Biosciences is a protein therapeutics company that develops an antibody design platform guided by artificial intelligence.

Highlights

Total Funding Amount
$99.30M
Funding Rounds
4
Investors
11
Acquisition
1
Employee Profiles
10

Details

Last Funding Type
Series B
Last Funding Money Raised
$75M
Industries
Artificial Intelligence,Biotechnology,Medical,Therapeutics
Founded date
Jan 1, 2019
Number Of Employee
11 - 50
Operating Status
Active
Legal Name
BigHat Biosciences, Inc.
Also Known As
BigHat

BigHat is a developer of an AI-guided protein therapeutic platform used to integrate antibody characterization lab with machine learning technologies to engineer molecules with more complex functions and better biophysical properties. The company is applying these design capabilities to develop new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$99.30M
BigHat Biosciences has raised a total of $99.30M in funding over 2 rounds. Their latest funding was raised on Jul 20, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 20, 2022 Series B $75M 9 Section 32 — Detail
Feb 10, 2021 Series A $19M 4 Andreessen Horowitz — Detail
Oct 1, 2020 Grant — 1 National Institute of Standards and Technology — Detail
Dec 19, 2019 Seed $5.30M 1 8VC — Detail

Investors

Number of Lead Investors
Number of Investors
4
11
BigHat Biosciences is funded by 11 investors. Section 32 and National Institute of Standards and Technology are the most recent investors.
Investor Name Lead Investor Funding Round
Section 32 Yes Series B
National Institute of Standards and Technology Yes Grant
Gaingels — Series B
8VC — Series B
AME Cloud Ventures — Series B
Amgen Ventures — Series B
Andreessen Horowitz — Series B
Bristol Myers Squibb — Series B
GRIDS Capital — Series B
Quadrille Capital — Series B
Show More

Employee Profiles

Number of Employee Profiles
10
BigHat Biosciences has 10 current employee profiles, including Board member Vineeta Agarwala
Vineeta Agarwala
Board member
Steven J. Kafka
Board member
Andrew Harrison
Board observer
Theresa Tribble
Advisor
Show More

Acquisition

BigHat Biosciences has acquired 1 organizations. Their most recent acquisition was Frugi Biotechnology on Mar 28, 2022. They acquired Frugi Biotechnology for 0.

Date Company Name
Industry Acquisition Type Price
Mar 28, 2022 Frugi Biotechnology
Biotechnology acquisition — Detail
Cointime
Содержание
компания